πŸ‡ΊπŸ‡Έ FDA
Patent

US 8747863

Vaccine for shigella

granted A61KA61K2039/6037A61K2039/6068

Quick answer

US patent 8747863 (Vaccine for shigella) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/6037, A61K2039/6068, A61K2039/6081, A61K39/02